Avid Bioservices, Inc. Common Stock
CDMO
CDMO was delisted on the 4th of February, 2025.
172 hedge funds and large institutions have $1.35B invested in Avid Bioservices, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 31 funds opening new positions, 53 increasing their positions, 58 reducing their positions, and 17 closing their positions.
82% more first-time investments, than exits
New positions opened: 31 | Existing positions closed: 17
56% more capital invested
Capital invested by funds: $869M → $1.35B (+$483M)
20% more funds holding in top 10
Funds holding in top 10: 5 → 6 (+1)
9% more funds holding
Funds holding: 158 → 172 (+14)
9% less repeat investments, than reductions
Existing positions increased: 53 | Existing positions reduced: 58
40% less call options, than puts
Call options by funds: $2.69M | Put options by funds: $4.47M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
State Street
Boston,
Massachusetts
|
+$32.9M |
| 2 |
Bank of Montreal
Toronto,
Ontario, Canada
|
+$16.9M |
| 3 |
Invesco
Atlanta,
Georgia
|
+$14M |
| 4 |
Jennison Associates
New York
|
+$12.6M |
| 5 |
DCM
Driehaus Capital Management
Chicago,
Illinois
|
+$12.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Snyder Capital Management
San Francisco,
California
|
-$8.38M |
| 2 |
KCM
Kornitzer Capital Management
Shawnee Mission,
Kansas
|
-$5.88M |
| 3 |
PCM
Portolan Capital Management
Boston,
Massachusetts
|
-$5.85M |
| 4 |
SAM
Silvercrest Asset Management
New York
|
-$5.65M |
| 5 |
JP Morgan Chase
New York
|
-$4.37M |
CDMO Hedge Fund Activity: Q2 2021 in Review
172 of the 5,746 institutional investors tracked by Wall St. Rank reported a position in Avid Bioservices, Inc. Common Stock (CDMO) for Q2 2021, worth a combined $1.35B — up 56% from $869M a quarter earlier.
Buyers outnumbered sellers: 31 funds opened new CDMO positions and 17 closed out — a net gain of 14 holders — while 53 added to existing stakes and 58 trimmed.
The largest buyer was State Street, adding an estimated $32.9M. The largest seller was Snyder Capital Management, cutting an estimated $8.38M.
- 172 institutional investors held Avid Bioservices, Inc. Common Stock (CDMO) as of Q2 2021, up from 158 in Q1 2021.
- Funds reported $1.35B of Avid Bioservices, Inc. Common Stock stock for Q2 2021, up 56% quarter-over-quarter.
- 31 funds opened new Avid Bioservices, Inc. Common Stock positions in Q2 2021 and 17 closed out, a net change of +14 holders.
- The largest Avid Bioservices, Inc. Common Stock buyer in Q2 2021 was State Street, an estimated $32.9M added.
- The largest Avid Bioservices, Inc. Common Stock seller in Q2 2021 was Snyder Capital Management, an estimated $8.38M sold.
Based on aggregated 13F filings for Q2 2021.